Fabien Ricard

648 total citations
13 papers, 299 citations indexed

About

Fabien Ricard is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Fabien Ricard has authored 13 papers receiving a total of 299 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pathology and Forensic Medicine, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Fabien Ricard's work include Lymphoma Diagnosis and Treatment (6 papers), Radiomics and Machine Learning in Medical Imaging (4 papers) and Medical Imaging Techniques and Applications (4 papers). Fabien Ricard is often cited by papers focused on Lymphoma Diagnosis and Treatment (6 papers), Radiomics and Machine Learning in Medical Imaging (4 papers) and Medical Imaging Techniques and Applications (4 papers). Fabien Ricard collaborates with scholars based in France, Australia and United States. Fabien Ricard's co-authors include Carole Lartizien, Émilie Niaf, Francesco Giammarile, Gilles Salles, Michel Meignan, Philippe Thiesse, Thomas Mognetti, Emmanuel Deshayes, Judith Trotman and Sami Boussetta and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and European Journal of Cancer.

In The Last Decade

Fabien Ricard

12 papers receiving 296 citations

Peers

Countries citing papers authored by Fabien Ricard

Since Specialization

Citations

This map shows the geographic impact of Fabien Ricard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabien Ricard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabien Ricard more than expected).

Fields of papers citing papers by Fabien Ricard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabien Ricard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabien Ricard. The network helps show where Fabien Ricard may publish in the future.

Co-authorship network of co-authors of Fabien Ricard

This figure shows the co-authorship network connecting the top 25 collaborators of Fabien Ricard. A scholar is included among the top collaborators of Fabien Ricard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabien Ricard. Fabien Ricard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	58 (PB046): Tumor-agnostic efficacy and safety of lirafugratinib, a highly selective FGFR2 inhibitor, in patients (pts) with advanced solid tumors with FGFR2 fusions or rearrangements (f/r): the ReFocus study 2024 ·European Journal of Cancer ·Antoine Hollebecque, Efrat Dotan, Chih‐Yi Liao, Desamparados Roda, Elisa Fontana, (unknown), (unknown), Do‐Youn Oh, François Ghiringhelli, Irene Moreno, (unknown), Vivek Subbiah, Andreas Varkaris, Mitesh J. Borad, (unknown), (unknown), (unknown), Fabien Ricard, Kuang‐Yu Jen, Alison M. Schram	1
2	Abstract OT3-24-01: ReFocus: A Phase 1/2 Study of the Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients with Advanced Solid Tumors Including Breast Cancer 2023 ·Cancer Research ·Suneel D. Kamath, David Tai, Irene Moreno, Hani M. Babiker, Zhaohui Jin, Changhoon Yoo, Fabien Ricard, (unknown), Jermaine Coward, Jia Liu, Frans L. Opdam, (unknown), Mariano Ponz‐Sarvisé, Jeffrey Yachnin, Richard D. Kim, Joon Oh Park, Vivek Subbiah, Alison M. Schram	0
3	Updated dose escalation results for ReFocus, a first-in-human study of highly selective FGFR2 inhibitor RLY-4008 in cholangiocarcinoma and other solid tumors. 2023 ·Journal of Clinical Oncology ·Mitesh J. Borad, Alison M. Schram, Richard D. Kim, Suneel D. Kamath, Vaibhav Sahai, Efrat Dotan, Robin Kate Kelley, Mariano Ponz‐Sarvisé, Do‐Youn Oh, Jeffrey Yachnin, Vaia Florou, Philippe A. Cassier, Joon Oh Park, Chih‐Yi Liao, Michael Millward, (unknown), Fabien Ricard, Antoine Hollebecque, Vivek Subbiah, Lipika Goyal	22
4	PET/CT assessment in follicular lymphoma using standardized criteria: central review in the PRIMA study 2014 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), Fabien Ricard, Michael Fulham, Marion Fournier, Michel Meignan, Thierry Lamy, Pierre Véra, Gilles Salles, Judith Trotman	36
5	Prognostic value of PET-CT after first-line therapy in patients with follicular lymphoma: a pooled analysis of central scan review in three multicentre studies 2014 ·The Lancet Haematology ·Judith Trotman, Stefano Luminari, Sami Boussetta, Annibale Versari, Jehan Dupuis, (unknown), Luigi Marcheselli, Alina Berriolo-Riedinger, Antonella Franceschetto, Anne Julian, Fabien Ricard, Luca Guerra, Corinne Haïoun, Irène Biasoli, Hervé Tilly, Massimo Federico, Gilles Salles, Michel Meignan	113
6	Prognostic value of PET-CT after frontline therapy in follicular lymphoma: A pooled analysis of central review in three multicenter studies. 2014 ·Journal of Clinical Oncology ·Judith Trotman, Stefano Luminari, Sami Boussetta, Annibale Versari, Jehan Dupuis, (unknown), Luigi Marcheselli, Alina Berriolo-Riedinger, Antonella Franceschetto, Anne Julian, Fabien Ricard, Luca Guerra, Corinne Haïoun, Irène Biasoli, Hervé Tilly, Massimo Federico, Gilles Salles, Michel Meignan	1
7	Computer-Aided Staging of Lymphoma Patients With FDG PET/CT Imaging Based on Textural Information 2013 ·IEEE Journal of Biomedical and Health Informatics ·Carole Lartizien, (unknown), Émilie Niaf, Fabien Ricard	53
8	PET-CT and diagnostic CT: The synergy of metabolic and morphological data in onco-haematology 2013 ·Diagnostic and Interventional Imaging ·Fabien Ricard, Francesco Giammarile, (unknown), C. Houzard, Évelyne Decullier, (unknown), (unknown), (unknown), Anne‐Sophie Michallet, Gilles Salles, P J Valette, (unknown)	7
9	TEP/TDM au FDG et bilan initial des lymphomes : du diagnostic au pronostic 2011 ·Médecine Nucléaire ·(unknown), Fabien Ricard, Francesco Giammarile	2
10	Additional Benefit of F-18 FDG PET/CT in the Staging and Follow-up of Pediatric Rhabdomyosarcoma 2011 ·Clinical Nuclear Medicine ·Fabien Ricard, (unknown), Emmanuel Deshayes, Thomas Mognetti, Philippe Thiesse, Francesco Giammarile	59
11	A Case of Advanced Non-Hodgkin's Lymphoma Involving the Prostate 2010 ·Clinical Nuclear Medicine ·(unknown), Florence Lachenal, Fabien Ricard, Catherine Chassagne‐Clément, Pierre-Étienne Heudel, (unknown), Catherine Sebban	2
12	Feasibility of iodine contrast enhanced CT-scan during a 18F-fluorodeoxyglucose Positron Emission Tomography 2009 ·Journal of Instrumentation ·C. Houzard, (unknown), Isabelle Morelec, Fabien Ricard, (unknown), François Cotton, Francesco Giammarile, D. Maintas	2
13	ESSAI D'ESTIMATION DIRECTE DES DIFFÉRENTS ÉLÉMENTS DE LA CARCASSE DU POULET EN VUE D'APPRÉCIER SON RENDEMENT EN VIANDE 1964 ·Annales de Zootechnie ·Fabien Ricard	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact